Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)
1,408.00
-2.00 (-0.14%)
Sep 11, 2024, 3:13 PM KST
Kangstem Biotech Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 3,751 | 5,856 | 4,681 | 7,542 | 9,969 | 7,681 | Upgrade
|
Short-Term Investments | 26,504 | 31,504 | 31,008 | 39,018 | 24,801 | 7,000 | Upgrade
|
Trading Asset Securities | - | - | 988.82 | 10,026 | 3,164 | 33,543 | Upgrade
|
Cash & Short-Term Investments | 30,255 | 37,360 | 36,678 | 56,585 | 37,933 | 48,224 | Upgrade
|
Cash Growth | 20.21% | 1.86% | -35.18% | 49.17% | -21.34% | 28.00% | Upgrade
|
Accounts Receivable | 749.22 | 721.6 | 1,567 | 1,225 | 660.58 | 332.51 | Upgrade
|
Other Receivables | 418.35 | 411.99 | 651.07 | 326.35 | 213.8 | 52.06 | Upgrade
|
Receivables | 1,818 | 1,134 | 2,218 | 1,551 | 874.38 | 384.57 | Upgrade
|
Inventory | 762.4 | 578.26 | 467.15 | 763.77 | 354.86 | 266.39 | Upgrade
|
Prepaid Expenses | 128 | 330.83 | 330.06 | 326.96 | 26.09 | 38.16 | Upgrade
|
Other Current Assets | 6,831 | 7,963 | 6,213 | 6,128 | 5,562 | 6,495 | Upgrade
|
Total Current Assets | 39,794 | 47,366 | 45,907 | 65,355 | 44,751 | 55,408 | Upgrade
|
Property, Plant & Equipment | 19,591 | 29,572 | 31,265 | 34,126 | 34,794 | 34,978 | Upgrade
|
Long-Term Investments | 7,925 | 2,950 | 1,833 | 2,198 | 670 | 20,633 | Upgrade
|
Other Intangible Assets | 351.24 | 440.12 | 1,041 | 991.53 | 1,121 | 1,789 | Upgrade
|
Long-Term Accounts Receivable | - | -0 | -0 | -0 | -0 | 0 | Upgrade
|
Other Long-Term Assets | 1,343 | 925.66 | 546.68 | 477.68 | 1,169 | 835.79 | Upgrade
|
Total Assets | 69,004 | 81,253 | 80,592 | 103,148 | 82,505 | 113,644 | Upgrade
|
Accounts Payable | 314.14 | 324.27 | 406.56 | 850.37 | 385.4 | 616.81 | Upgrade
|
Accrued Expenses | 364.05 | 483.99 | 436.08 | 421.19 | 304.28 | 284.76 | Upgrade
|
Short-Term Debt | 3,330 | 2,616 | 2,566 | 2,264 | 2,198 | 12,345 | Upgrade
|
Current Portion of Long-Term Debt | 400 | 5,530 | 3,700 | 3,500 | 355.56 | 83.33 | Upgrade
|
Current Portion of Leases | 570.1 | 808.9 | 752.43 | 844.37 | 829.4 | 472.54 | Upgrade
|
Current Unearned Revenue | 330 | 330 | 334.05 | 235.77 | 300.01 | 522.08 | Upgrade
|
Other Current Liabilities | 7,577 | 8,501 | 6,072 | 9,074 | 7,833 | 6,274 | Upgrade
|
Total Current Liabilities | 12,885 | 18,594 | 14,267 | 17,191 | 12,206 | 20,599 | Upgrade
|
Long-Term Debt | 3,180 | 3,380 | 5,230 | 5,630 | 12,427 | 14,804 | Upgrade
|
Long-Term Leases | 181.58 | 1,274 | 1,120 | 1,805 | 2,348 | 3,228 | Upgrade
|
Other Long-Term Liabilities | 1,268 | 6,375 | 6,301 | 6,323 | 6,144 | 5,579 | Upgrade
|
Total Liabilities | 17,515 | 31,130 | 27,890 | 31,862 | 33,866 | 44,924 | Upgrade
|
Common Stock | 28,027 | 27,969 | 18,969 | 18,969 | 12,418 | 10,425 | Upgrade
|
Additional Paid-In Capital | 174,869 | 174,895 | 163,374 | 163,374 | 131,311 | 134,808 | Upgrade
|
Retained Earnings | -158,477 | -159,354 | -137,201 | -117,054 | -95,670 | -77,232 | Upgrade
|
Comprensive Income & Other | 7,070 | 4,469 | 4,194 | 2,751 | 3,290 | 1,100 | Upgrade
|
Total Common Equity | 51,489 | 47,978 | 49,336 | 68,039 | 51,350 | 69,101 | Upgrade
|
Minority Interest | - | -3,494 | -2,110 | -2,070 | -2,981 | -2,001 | Upgrade
|
Shareholders' Equity | 51,489 | 50,123 | 52,702 | 71,286 | 48,639 | 68,719 | Upgrade
|
Total Liabilities & Equity | 69,004 | 81,253 | 80,592 | 103,148 | 82,505 | 113,644 | Upgrade
|
Total Debt | 7,662 | 13,609 | 13,369 | 14,044 | 18,159 | 30,933 | Upgrade
|
Net Cash (Debt) | 22,593 | 23,751 | 23,309 | 42,542 | 19,775 | 17,291 | Upgrade
|
Net Cash Growth | 81.80% | 1.90% | -45.21% | 115.13% | 14.37% | -14.67% | Upgrade
|
Net Cash Per Share | 451.66 | 584.98 | 614.40 | 1527.64 | 886.87 | 829.71 | Upgrade
|
Filing Date Shares Outstanding | 56.03 | 55.94 | 37.94 | 37.94 | 24.84 | 20.85 | Upgrade
|
Total Common Shares Outstanding | 56.03 | 55.94 | 37.94 | 37.94 | 24.84 | 20.85 | Upgrade
|
Working Capital | 26,909 | 28,772 | 31,640 | 48,165 | 32,544 | 34,809 | Upgrade
|
Book Value Per Share | 918.97 | 857.70 | 1300.44 | 1793.43 | 2067.50 | 3314.26 | Upgrade
|
Tangible Book Value | 51,138 | 47,538 | 48,295 | 67,048 | 50,229 | 67,311 | Upgrade
|
Tangible Book Value Per Share | 912.70 | 849.83 | 1273.00 | 1767.30 | 2022.35 | 3228.44 | Upgrade
|
Land | 3,927 | 8,249 | 7,984 | 7,984 | 7,798 | 1,243 | Upgrade
|
Buildings | 9,241 | 10,920 | 10,596 | 10,596 | 10,211 | 2,762 | Upgrade
|
Machinery | 414.67 | 595.05 | 590.8 | 533.4 | 539.11 | 522.21 | Upgrade
|
Construction In Progress | 548.74 | 310.22 | 23.52 | 50.96 | - | 25,964 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.